Mark Hopman, Chief Commercial Officer at Beta Bionics, Inc. (BBNX), sold 32,316 shares at $16.61 ($537K) on 2025-08-19, disclosed to the SEC on 2025-08-20.
Scheduled sale ($537k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.61 | 16,158 | $268K | 50.0% |
| 2 | $16.61 | 16,158 | $268K | 50.0% |
| Total | $16.61 avg | 32,316 | $537K | 100% |
| Filing → |
| BBNX | SELL | 2026-09-17 | $620K | — | Filing → |
| BBNX | SELL | 2026-09-15 | $12K | — | Filing → |
| BBNX | SELL | 2026-09-10 | $681K | — | Filing → |